Early experience with the Excluder® iliac branch endoprosthesis
C Ferrer1, F De Crescenzo, C Coscarella
1Department of Vascular Surgery Hospital S. Camillo Forlanini, Rome, Italy - cfrrr83@gmail.com.
The Journal of Cardiovascular Surgery
|July 11, 2014
Summary
The Gore® Excluder® Iliac Branch Endoprosthesis (IBE) shows promising early results for treating iliac artery aneurysms. This device offers a feasible and safe option for aorto-iliac disease, with high technical success and no 30-day mortality.
Area of Science:
- Vascular Surgery
- Endovascular Repair
- Aorto-Iliac Disease Management
Background:
- Common iliac artery (CIA) dilation poses challenges in endovascular aneurysm repair (EVAR).
- Hypogastric artery embolization, a common strategy, can lead to ischemic complications.
- Alternative solutions are needed for effective CIA aneurysm treatment.
Purpose of the Study:
- To evaluate the early outcomes of the Gore® Excluder® Iliac Branch Endoprosthesis (IBE).
- To assess the safety and feasibility of IBE in treating iliac aneurysms, with or without associated abdominal aortic aneurysms.
Main Methods:
- A prospective study involving 7 Gore IBE implantations in 5 patients.
- Evaluation of technical success, 30-day mortality, and complications.
- Data collected between November 2013 and April 2014.
Main Results:
- 100% technical success and branch patency were achieved.
- No 30-day mortality was observed.
- One case required endovascular relining due to iliac leg compression at the aortic bifurcation.
Conclusions:
- The Gore IBE device is a feasible and safe option for managing aorto-iliac disease.
- Further long-term studies are required to fully assess the endograft's performance.
- Early results suggest a favorable safety profile for IBE in complex iliac artery repairs.
